The CryoVault® Bench Top Freezer was introduced by Meissner’s David Lange, Senior Product Engineer Project Manager. Jessica McRoskey, R&D Process Development Engineer at Meissner, introduced the SepraPor® ultrafiltration hollow fiber portfolio and outlined how Meissner’s unique membrane characterization process enhances the consistent performance of our hollow fiber filters for both microfiltration and ultrafiltration applications.
Images
Meissner Filtration Products Has Shortened Its Name to Meissner
It’s official – Meissner has shortened its name to align more closely with the agile, responsive organization that our clients have come to rely on for providing more than critical filtration solutions. For the last 40 years, Meissner has expanded its expertise in the pharma and biotech industries beyond filtration into single-use systems, automatic aseptic filling systems, freeze and thaw platforms for critical biopharmaceuticals, and laboratory and technical services.
The Meissner name and logo have been streamlined just like our timelines from receipt of order to delivery of critical manufacturing solutions.
Meissner will continue to manufacture the same high-quality products, while delivering the same level of expertise, service, and responsiveness that our clients depend on. The Meissner logo has been updated, too, to reflect this name change, and over time, our product labels, packaging, and documentation will also be updated to better align with how industry already refers to us, as Meissner.
Download the Press Release.
Meissner Announces Location of Future Manufacturing Site in Athens, Georgia!
Meissner Corporation, a leading manufacturer of advanced microfiltration and single-use systems for production of pharmaceutical drugs, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens, Georgia. The project is expected to create over 1,700 new jobs over the next eight years. Meissner’s new facility will include state-of-the-art cleanroom facilities and laboratories, as well as R&D, and office spaces. Meissner expects to begin operations in early 2026 and will be hiring for a broad range of roles. Interested parties can visit the employment listings on www.meissner.com. The Athens, GA location provides direct access to work with schools such as the University of Georgia, Georgia Institute of Technology, and Athens Technical College for internship and collaboration opportunities through relevant programs of study. The project was supported by the Georgia Department of Economic Development, Invest Athens, Georgia Power, and Georgia Quick Start.
Take a drone tour.
Download the Press Release.
Biotech Week Boston/BPI Virtual Event 2020 Interview – “What’s New at Meissner?”
The BPI US virtual event will run September 21-24, 2020. In this video snippet, Rizwan Chaudhrey, Biotech Blogger, catches up with Karisa Koenig, Director of Marketing, during the event to discuss the opening of Meissner’s Castlebar, Ireland, manufacturing site, the launch of M-Flex® TPE tubing as a direct replacement option in single-use systems for the C-Flex® 374 shortage, and the award-winning CryoVault® freeze/thaw platform for bulk drug substance. Meissner’s Live Lab presentation, delivered by Tristan Winneker, Product Manager, officially launched their portfolio of Seprapor® hollow fiber filters during the show. The presentation can be viewed On-Demand through the Live Labs section on the virtual portal. A free Exhibit Pass to the event can be requested by visiting https://bit.ly/2FIrLvN. Meissner will be hosting a Solutions Provider booth where visitors can video chat with our team and download product information.
Single-Use Roundtable Discussion is Featured in American Pharmaceutical Review Magazine
A Roundtable panel fielded a series of questions centering on whether single-use technologies had finally become “standard” for biopharmaceutical manufacturing, and if there were unforeseen benefits/disadvantages to the adoption of this technology. Max Blomberg, Executive Director of Operations, participated on behalf of Meissner, along with representatives from companies like Catalent, Advantapure, BioPlan Associates, Pharmatech Associates, and Sartorius.
Meissner’s CryoVault® Freeze & Thaw Solution
This overview of the CryoVault® Platform takes you inside a demo suite that provides Meissner’s clients the opportunity to experience this end-to-end solution for the freeze and thaw of critical biopharmaceuticals. Once inside the demo suite, clients can interact with the CryoVault® containers, and all of the supporting infrastructure. This includes pallets, pallet movers, accessory carts for fill and dispense, mixers and large and small scale freezers and secure shippers to ship BDS and drug product. CryoVault® is scalable, robust, and completely single-use. Join, Robert Davies, Meissner’s Product Manager Process Solutions/Integrated Solutions, as we explore our client demo suite featuring our CryoVault® freeze and thaw platform.